Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Nutrition for the Child with Sickle Cell Anemia
source: Academy of Nutrition and Dietetics
year: 2018
authors: Marisa Moore
summary/abstract:Sickle Cell Disease (SCD), also called Sickle Cell Anemia, is a genetic red blood cell disorder that causes blood cells to take on a sickle or crescent shape. In the U.S., SCD is most common among African Americans and Hispanic Americans. People with SCD often experience episodes of pain, fatigue and frequent infections. SCD is associated with low calcium intake, vitamin D deficiency and poor appetite. All of these can lead to delayed growth and development in children.
If your child gets enough calcium, keep up the good work! However, calcium alone is not enough. Calcium is effective at building strong bones only if your child also gets enough vitamin D. Emory University Associate Professor of Pediatrics Dr. Ify Osunkwo explains, “Many sickle cell disease patients are vitamin D deficient due to their darker skin, lack of dairy intake and limited sun exposure. If they drink milk, are out in the sun and open to eating dairy, they tend to fare better.”
read more
+myBinderRelated Content
-
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now availab...Medunik USA, a company dedicated to impr...
-
Sickle Cell Treatment Endari Now Available in the United StatesEmmaus Life Sciences has announced that ...
-
Marijuana Use and Health Behaviors in a US Clinic Sample of Patients With Sickle Cell DiseaseIntroduction: As marijuana use becomes ...
-
Calimmune Expands Lentiviral Gene Therapy Pipeline Through License of Sickle Cell Disease Therapeutic CandidateLicense of Gamma-Globin from Cincinnati ...
-
Novel Sickle Cell Drug Causes Radical Results in End of Life PatientsThis week the FDA approved a novel treat...
-
Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell DiseaseBACKGROUND: In utero hematopoietic cell ...
-
First Sickle Cell Patient Dosed in Phase 2a of IMR-687This morning, Imara Inc. announced that ...
Don’t forget to join the oneSCDvoice community!
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.
